Linked Data API

Show Search Form

Search Results

1141118
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-07-22
answering body
Department for Environment, Food and Rural Affairs more like this
answering dept id 13 more like this
answering dept short name Environment, Food and Rural Affairs more like this
answering dept sort name Environment, Food and Rural Affairs more like this
hansard heading Food: Imports more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment he has made of the potential effect of the UK leaving the EU without a deal on 31 October 2019, on the supply of fresh produce. more like this
tabling member constituency Bristol East remove filter
tabling member printed
Kerry McCarthy more like this
uin 280215 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-08-14more like thismore than 2019-08-14
answer text <p>The UK’s high degree of food security is built on access to a range of sources including strong domestic production and imports from other countries. This will continue to be the case whether we leave the EU with or without a deal.</p><p> </p><p>Half of the food we eat is produced in the UK. The rest of our food is imported, with 30% coming from the EU and 20% from other countries. There will not be an overall shortage of food in the UK as a result of a no deal Brexit. However, there may be fluctuations in the availability and choice of certain seasonal products, such as fresh fruit. The UK has a high degree of self-sufficiency in some vegetables year-round including root vegetables, cabbage and potatoes, as well as certain fruits during the summer harvest season including strawberries and apples.</p><p> </p><p>Over the last three years Government has been working to prioritise the smooth flow of trade, particularly at channel ports, to minimise any disruption if the UK leaves the EU without a deal. This includes cross Government work to ensure traders and hauliers in the UK and the EU are prepared for changes to exporting and importing requirements; ensuring our approach to imports achieves a smooth flow of goods at UK ports; working with stakeholders, major ports and airports to ensure that they are making their own preparations for leaving the EU; and developing traffic management plans to manage any potential delays at the ports, for example Operation Brock in Kent.</p><p> </p>
answering member constituency Camborne and Redruth more like this
answering member printed George Eustice more like this
question first answered
less than 2019-08-14T07:50:21.777Zmore like thismore than 2019-08-14T07:50:21.777Z
answering member
3934
label Biography information for George Eustice more like this
tabling member
1491
label Biography information for Kerry McCarthy more like this
1141119
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-07-22
answering body
Department for Environment, Food and Rural Affairs more like this
answering dept id 13 more like this
answering dept short name Environment, Food and Rural Affairs more like this
answering dept sort name Environment, Food and Rural Affairs more like this
hansard heading Food: Storage more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment he has made of the potential effect of the UK leaving the EU without a deal on 31 October 2019 on the UK’s food warehousing and storage capacity. more like this
tabling member constituency Bristol East remove filter
tabling member printed
Kerry McCarthy more like this
uin 280216 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-08-27more like thismore than 2019-08-27
answer text <p>Defra Ministers and officials meet regularly with the food industry to understand the potential impacts of a no deal exit and support contingency planning by the industry. This has included discussion on storage capacity in the UK at that time of year.</p><p> </p> more like this
answering member constituency Camborne and Redruth more like this
answering member printed George Eustice more like this
question first answered
less than 2019-08-27T14:13:40.877Zmore like thismore than 2019-08-27T14:13:40.877Z
answering member
3934
label Biography information for George Eustice more like this
tabling member
1491
label Biography information for Kerry McCarthy more like this
1140209
registered interest false more like this
date less than 2019-07-18more like thismore than 2019-07-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cystic Fibrosis: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what recent discussions there have been between Vertex Pharmaceuticals and NHS England with on cystic fibrosis medicines. more like this
tabling member constituency Bristol East remove filter
tabling member printed
Kerry McCarthy more like this
uin 278928 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-23more like thismore than 2019-07-23
answer text <p>Discussions with Vertex, including meetings, are ongoing.</p><p>NHS England and NHS Improvement are leading the negotiations with Vertex and have made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients.</p><p>The Government fully supports NICE, NHS England and NHS Improvement in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to strongly urge Vertex to accept NHS England’s and NHS Improvement’s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.</p>
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
grouped question UIN 278929 more like this
question first answered
less than 2019-07-23T16:49:59.47Zmore like thismore than 2019-07-23T16:49:59.47Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
1491
label Biography information for Kerry McCarthy more like this
1140210
registered interest false more like this
date less than 2019-07-18more like thismore than 2019-07-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cystic Fibrosis: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will set a deadline for NHS England and Vertex Pharmaceuticals to come to an agreement to enable access to cystic fibrosis medicines produced by that company. more like this
tabling member constituency Bristol East remove filter
tabling member printed
Kerry McCarthy more like this
uin 278929 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-23more like thismore than 2019-07-23
answer text <p>Discussions with Vertex, including meetings, are ongoing.</p><p>NHS England and NHS Improvement are leading the negotiations with Vertex and have made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients.</p><p>The Government fully supports NICE, NHS England and NHS Improvement in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to strongly urge Vertex to accept NHS England’s and NHS Improvement’s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.</p>
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
grouped question UIN 278928 more like this
question first answered
less than 2019-07-23T16:49:59.517Zmore like thismore than 2019-07-23T16:49:59.517Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
1491
label Biography information for Kerry McCarthy more like this
1140410
registered interest false more like this
date less than 2019-07-18more like thismore than 2019-07-18
answering body
Department for Environment, Food and Rural Affairs more like this
answering dept id 13 more like this
answering dept short name Environment, Food and Rural Affairs more like this
answering dept sort name Environment, Food and Rural Affairs more like this
hansard heading Animal Experiments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Environment, Food and Rural Affairs, what steps he is taking to ensure that there is no duplication of animal testing for chemical registrations in the event that the UK leaves the EU without an agreement. more like this
tabling member constituency Bristol East remove filter
tabling member printed
Kerry McCarthy more like this
uin 278930 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-23more like thismore than 2019-07-23
answer text <p>We are determined that there should be no need for any additional animal testing for a chemical that has already been registered to EU Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) if the UK leaves the EU without a deal. In such a scenario, the UK system that we will put in place (UK REACH) will retain the ‘last resort principle’ – that companies can only use animal testing as a last resort.</p><p> </p><p>We have also ensured that under UK REACH the information requirements would be the same as under EU REACH. Businesses will therefore be able to confirm their registrations by submitting the same technical information that was required by EU REACH.</p><p> </p><p> </p> more like this
answering member constituency Suffolk Coastal more like this
answering member printed Dr Thérèse Coffey more like this
question first answered
less than 2019-07-23T15:42:32.417Zmore like thismore than 2019-07-23T15:42:32.417Z
answering member
4098
label Biography information for Dr Thérèse Coffey more like this
tabling member
1491
label Biography information for Kerry McCarthy more like this